Cargando…
Bisphosphonate-induced atypical femoral fracture in tandem: long-term follow-up is warranted
SUMMARY: Although bisphosphonates (BPs) are mainly used for the treatment of osteoporosis and are generally safe, long-term use and more dosage as utilised in malignant conditions may be associated with the rare adverse event of an atypical femoral fracture (AFF). Occasionally, the risk of developin...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422258/ https://www.ncbi.nlm.nih.gov/pubmed/36001019 http://dx.doi.org/10.1530/EDM-22-0249 |